Healthcare DIVE June 30, 2023
Nick Paul Taylor

Dive Brief:

  • The U.S. Food and Drug Administration is asking for public input on the transition to at-home care and how regulators can support enabling technologies.
  • As part of its push to advance health equity, the FDA has posed a series of home-care questions to the medtech industry, including a query about how it can support the development of devices for use in non-clinical care settings.
  • Other questions cover how digital health technologies can support home-based healthcare, the device design attributes that facilitate use outside of clinical settings and methods for generating data to inform regulatory reviews.

Dive Insight:

The development of remote patient-monitoring devices and other connected medical technologies has made it possible to treat more patients...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Equity/SDOH, FDA, Govt Agencies, Healthcare System, Home, Patient / Consumer, Provider, Technology
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article